JM

John Moore

Nyrada Inc | Non-Executive Chairman, Non-Executive Director
Mr Moore currently serves as Chairman of Trialogics, a clinical trial informatics business, Chairman of Scientific Industries (SCND-OTCQB), a producer of laboratory instruments for the life sciences industry and Chairman of Cormetech, a manufacturer of environmental catalysts. John was CEO of Acorn Energy from 2006 to 2015, during which time the CoaLogix business was acquired for US$11 million and sold for US$101 million, and the Comverge business listed in the US before its sale to Constellation Energy. In 2002 he was a Partner and CEO of Edson Moore Healthcare Ventures and acquired for US$148 million a portfolio of sixteen drug delivery investments from Elan Pharmaceuticals. He is a member of Risk Committee.

Company and Roles

Company
Title
Tenure
Since
NYR
Nyrada Inc
  • Non-Executive Chairman
  • Non-Executive Director
4yrs, 11mthJun 2019

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
NYR
Nyrada Inc
14/03/24358,423N/A2,400,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NYR
Nyrada Inc
14/03/24
Expiry
1,200,000$0.100$120,000Options expired
NYR
Nyrada Inc
29/06/21
Issued
76,923$0.260$20,000Placement
NYR
Nyrada Inc
02/03/21
Buy
500$0.204$102As advised by the company
NYR
Nyrada Inc
02/03/21
Buy
19,000$0.350$6,650On-market trade
NYR
Nyrada Inc
25/11/20
Buy
32,000$0.206$6,600On-market trade